These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 8251321

  • 1. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
    Uyeki TM, Barry FL, Rosenthal SM, Mathias RS.
    Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
    [Abstract] [Full Text] [Related]

  • 2. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
    Alon U, Chan JC.
    Am J Nephrol; 1985 Oct; 5(1):9-13. PubMed ID: 3970081
    [Abstract] [Full Text] [Related]

  • 3. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N, Monnens LA.
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract] [Full Text] [Related]

  • 4. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O, Jacobsen BB.
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [Abstract] [Full Text] [Related]

  • 5. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
    Kirchlechner V, Koller DY, Seidl R, Waldhauser F.
    Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic diabetes insipidus. Radiological and clinical features.
    Hartenberg MA, Cory M, Chan JC.
    Int J Pediatr Nephrol; 1985 Jun; 6(4):281-6. PubMed ID: 4093246
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
    Knoers N, Monnens LA.
    Pediatr Nephrol; 1992 Sep; 6(5):476-82. PubMed ID: 1457333
    [Abstract] [Full Text] [Related]

  • 8. Hydrochlorothiazide, amiloride and tolmetin in the treatment of diabetes insipidus of Brattleboro rats.
    Alon U, Wellons MD, Chan JC.
    Med Biol; 1985 Sep; 63(3):117-22. PubMed ID: 4068772
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T, Nsota J, Martin-Coignard D, Champion G.
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [Abstract] [Full Text] [Related]

  • 10. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW.
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [Abstract] [Full Text] [Related]

  • 11. [Angiotensin and saluretics in nephrogenic diabetes insipidus of early infancy].
    Reimold EW.
    Z Kinderheilkd; 1967 Jul; 101(1):6-19. PubMed ID: 4301709
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient.
    Konoshita T, Kuroda M, Kawane T, Koni I, Miyamori I, Tofuku Y, Mabuchi H, Takeda R.
    Horm Res; 2004 Jul; 61(2):63-7. PubMed ID: 14646392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
    Pattaragarn A, Alon US.
    Pediatr Nephrol; 2003 Oct; 18(10):1073-6. PubMed ID: 12883974
    [Abstract] [Full Text] [Related]

  • 15. Congenital nephrogenic diabetes insipidus. Report of a case.
    Zhang YM, Zhang XX, Li XL.
    Chin Med J (Engl); 1985 Oct; 98(10):775-8. PubMed ID: 3938705
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of severe lithium-induced polyuria with amiloride.
    Kosten TR, Forrest JN.
    Am J Psychiatry; 1986 Dec; 143(12):1563-8. PubMed ID: 3538913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic Pitfalls of a Newborn with Congenital Nephrogenic Diabetes Insipidus.
    Güran Ö, Güven S, Kırmızıbekmez H, Akgün Doğan Ö, Karadeniz Bilgin L.
    J Clin Res Pediatr Endocrinol; 2023 Feb 23. PubMed ID: 36815512
    [Abstract] [Full Text] [Related]

  • 19. Novel AQP2 mutation causing congenital nephrogenic diabetes insipidus: challenges in management during infancy.
    Rugpolmuang R, Deeb A, Hassan Y, Deekajorndech T, Shotelersuk V, Sahakitrungruang T.
    J Pediatr Endocrinol Metab; 2014 Jan 23; 27(1-2):193-7. PubMed ID: 23950570
    [Abstract] [Full Text] [Related]

  • 20. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
    Kaulitz R, Brodehl J.
    Klin Padiatr; 1989 Jan 23; 201(6):425-30. PubMed ID: 2601280
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.